These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 10282282)

  • 1. Minimizing antitrust and corporate liability risks.
    Weissburg C
    Health Prog; 1987 Apr; 68(3):68-73, 90. PubMed ID: 10282282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital-physician collaboration and competition: the antitrust connection.
    Enders RJ
    Healthc Financ Manage; 1986 Apr; 40(4):60-8. PubMed ID: 10275461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding antitrust: focus on the relevant market.
    Enders RJ
    Healthc Financ Manage; 1986 Feb; 40(2):25-32. PubMed ID: 10275004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are PPOs a competitive force or antitrust risk?
    Enders RJ
    Healthc Financ Manage; 1986 May; 40(5):52-60. PubMed ID: 10276171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dodging the bullet: avoiding conspiracy claims in professional staff disputes.
    Piché GR
    Hosp Health Serv Adm; 1988; 33(4):531-42. PubMed ID: 10290103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitrust implications of allied health practitioner privilege decisions and hospital-physician exclusive contracts.
    Miles JJ
    Med Staff Couns; 1988; 2(1):19-26. PubMed ID: 10289814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How can PPOs control prices without violating antitrust laws?
    Fried JM
    Hosp Prog; 1984 Mar; 65(3):34-7. PubMed ID: 10265221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can provider antitrust suits against payers be successful?
    Enders RJ
    Healthc Financ Manage; 1986 Jun; 40(6):72-80. PubMed ID: 10276682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exclusive contracts and hospital privileges--the physician's perspective.
    Chenen AR
    Med Staff Couns; 1988; 2(1):35-40. PubMed ID: 10285826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing antitrust liability after Maricopa.
    Walsh JH; Feller H
    GHAA J; 1986; 7(2):57-74. PubMed ID: 10280126
    [No Abstract]   [Full Text] [Related]  

  • 11. The antitrust perspective on health industry competition.
    Miller FH
    J Health Hum Resour Adm; 1989; 12(1):128-48. PubMed ID: 10296433
    [No Abstract]   [Full Text] [Related]  

  • 12. The development of preferred provider organizations and its antitrust implications.
    Maram BS
    J Med Pract Manage; 1985 Oct; 1(2):130-5. PubMed ID: 10281825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical staff privileges: is antitrust a real issue for providers?
    Enders RJ
    Healthc Financ Manage; 1986 Mar; 40(3):64-70. PubMed ID: 10275454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical staff privileges and the antitrust laws: a view from the Federal Trade Commission.
    Horoschak MJ
    Med Staff Couns; 1992; 6(2):17-24. PubMed ID: 10116790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferred provider organizations, price-fixing and Section 1 of the Sherman Act.
    Bluhm RJ
    Health Matrix; 1987; 5(3):9-16. PubMed ID: 10285386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exclusive contracts under antitrust attack.
    Reed TJ; Allen HS
    Hosp Med Staff; 1982 Nov; 11(11):2-9. PubMed ID: 10257181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimizing antitrust risks of Blue Cross and Blue Shield plans.
    Steele CJ
    J Contemp Health Law Policy; 1988; 4():227-72. PubMed ID: 10288422
    [No Abstract]   [Full Text] [Related]  

  • 18. Hospital law: the spiraling cost of litigation.
    Hollowell EE
    South Hosp; 1984; 52(5):66-7. PubMed ID: 10268456
    [No Abstract]   [Full Text] [Related]  

  • 19. Preferred provider organizations and antitrust policy: some recent issues.
    Costillo LB
    Health Matrix; 1986; 4(2):22-5. PubMed ID: 10278618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coastal Neuro-Psychiatric broadens state action exemption protection for hospital credentialing decisions.
    Lipsetts PG
    Health Law Vigil; 1986 Aug; 9(17):9-11. PubMed ID: 10278410
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.